Outlook Response

I enjoyed "Outlook 2002: Jobs abundant despite recession,"1 because it provided an interesting historical perspective to the current biotech job market. However, I believe that it is dangerous to start making the job market look so hot that just about anyone can fall into a good, high-paying job right out of a grad program or postdoc. I don't think that this helps anyone who is job seeking--it only creates frustration and a feeling of abandonment. Many articles in the non-science media have pr

Written byDavid Jensen
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Many articles in the non-science media have promoted bio-technology as the latest, greatest place to find a job. While this could indeed be true, it has a great deal to do with the specific niche that a person studies and the lab. You can't jump into molecular biology and land, as your article states, "high salaries, unheard of salaries for people with [molecular biology] skills."

I'd prefer to see the excellent Profession section of The Scientist continue to develop articles that aid and assist the job seeker, rather than thumbing the nose at those hundreds or thousands of people who may be caught in academic studies that aren't of interest to bio-industry.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies